Furthermore, we applied the BRCA1/2 CNV calling-pipeline to the data generated by NGS analysis of twelve FFPE tumor samples with known germline variants (Table 1, Additional file 4: Table S3, P01–13). This evidence concerns the gene BRCA1 and neoplasm.